Caricamento...

Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors

This study uses wholesale medication acquisition costs and Medicare claims data to assess how prices of existing tumor necrosis factor inhibitors changed in response to the market entry of new tumor necrosis factor inhibitors.

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Intern Med
Autori principali: San-Juan-Rodriguez, Alvaro, Prokopovich, Max V., Shrank, William H., Good, Chester B., Hernandez, Inmaculada
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2019
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503568/
https://ncbi.nlm.nih.gov/pubmed/30776053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.7656
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !